Suppr超能文献

相似文献

1
Dialysis Modalities and HDL Composition and Function.
J Am Soc Nephrol. 2015 Sep;26(9):2267-76. doi: 10.1681/ASN.2014030309. Epub 2015 Mar 5.
5
Dysfunctional high-density lipoprotein in patients on chronic hemodialysis.
J Am Coll Cardiol. 2012 Dec 11;60(23):2372-9. doi: 10.1016/j.jacc.2012.09.013. Epub 2012 Nov 7.
7
HDL2 of heavy alcohol drinkers enhances cholesterol efflux from raw macrophages via phospholipid-rich HDL 2b particles.
Alcohol Clin Exp Res. 2008 Jun;32(6):991-1000. doi: 10.1111/j.1530-0277.2008.00660.x.
8
Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease.
Transl Res. 2009 Feb;153(2):77-85. doi: 10.1016/j.trsl.2008.11.007. Epub 2008 Dec 10.

引用本文的文献

1
High-density lipoproteins. Part 2. Impact of disease states on functionality.
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
2
HDL-Cholesterol and Triglycerides Dynamics: Essential Players in Metabolic Syndrome.
Antioxidants (Basel). 2025 Apr 3;14(4):434. doi: 10.3390/antiox14040434.
3
Risk prediction of cardiovascular events in peritoneal dialysis patients.
BMC Nephrol. 2025 Apr 5;26(1):177. doi: 10.1186/s12882-025-04091-6.
4
ApoM and Major Adverse Cardiovascular Events in Chronic Kidney Disease: A Prospective Cohort Study.
Arterioscler Thromb Vasc Biol. 2025 Apr;45(4):496-505. doi: 10.1161/ATVBAHA.124.322367. Epub 2025 Mar 6.
5
Association of Small HDL Subclasses with Mortality Risk in Chronic Kidney Disease.
Antioxidants (Basel). 2024 Dec 11;13(12):1511. doi: 10.3390/antiox13121511.
8
Serum HDL-C subfractions as predictors of cardiovascular calcification in hemodialysis patients: novel insights and clinical implications.
Front Med (Lausanne). 2024 Jul 31;11:1391057. doi: 10.3389/fmed.2024.1391057. eCollection 2024.
9
The importance of paraoxonase 1 activity in chronic kidney disease.
Ren Fail. 2024 Dec;46(2):2376930. doi: 10.1080/0886022X.2024.2376930. Epub 2024 Jul 10.
10
Bridging the Gap Between the Bench and Bedside: Clinical Applications of High-density Lipoprotein Function.
J Atheroscler Thromb. 2024 Sep 1;31(9):1239-1248. doi: 10.5551/jat.RV22020. Epub 2024 Jun 27.

本文引用的文献

2
HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.
J Am Soc Nephrol. 2015 Feb;26(2):484-92. doi: 10.1681/ASN.2013080816. Epub 2014 Jul 10.
3
HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype.
J Am Soc Nephrol. 2014 Nov;25(11):2658-68. doi: 10.1681/ASN.2013111212. Epub 2014 May 22.
4
HDL cholesterol is not associated with lower mortality in patients with kidney dysfunction.
J Am Soc Nephrol. 2014 May;25(5):1073-82. doi: 10.1681/ASN.2013050482. Epub 2014 Mar 7.
5
Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.
Nephrol Dial Transplant. 2014 Aug;29(8):1554-62. doi: 10.1093/ndt/gfu022. Epub 2014 Feb 25.
6
Aging affects high-density lipoprotein composition and function.
Biochim Biophys Acta. 2013 Sep;1831(9):1442-8. doi: 10.1016/j.bbalip.2013.06.004. Epub 2013 Jun 20.
7
Diminished antioxidant activity of high-density lipoprotein-associated proteins in chronic kidney disease.
J Am Heart Assoc. 2013 Apr 4;2(2):e000104. doi: 10.1161/JAHA.112.000104.
8
Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease.
Arch Med Sci. 2013 Feb 21;9(1):8-13. doi: 10.5114/aoms.2013.33189. Epub 2013 Feb 10.
9
Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study.
Atherosclerosis. 2013 May;228(1):230-6. doi: 10.1016/j.atherosclerosis.2013.01.046. Epub 2013 Feb 18.
10
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2.
Immunity. 2013 Apr 18;38(4):754-68. doi: 10.1016/j.immuni.2013.02.009. Epub 2013 Mar 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验